Heidi A. Hamann, PhD
University of Arizona Cancer CenterTucson, AZ
Department of Clinical Sciences (Division of Behavioral & Communication Sciences), Department of Psychiatry (Division of Psychology), Harold C. Simmons Cancer Center, University ?of Texas Southwestern Medical Center, Dallas, Texas
Authored Items
Simon Craddock Lee, PhD, MPH, Heidi A. Hamann, PhD, Magalis Z. Tijerina, BA, Cynthia Ortiz, MPH, Claudia Chavez, MBA, Noel Santini, MD, David E. Gerber, MD
November 2018 Vol 9, NO 11
While adherence to annual screening exceeded 90% in the National Lung Screening Trial, the trial population was disproportionately white, educated, and received care in the tightly controlled environment of a clinical trial.
April 2013 Vol 4, No 2
Since the publication of the positive results of the National Lung Screening Trial (NLST)—the first lung cancer screening trial to demonstrate a reduction in lung cancer mortality—in the New England Journal of Medicine in 2011, several uncertainties regarding implementation of widespread lung cancer screening have arisen.
Last modified: April 14, 2021